Nisizawa T, Ewenstein B M, Uehara H, McGovern D, Nathenson S G
Immunogenetics. 1981;12(1-2):33-44. doi: 10.1007/BF01561649.
Biochemical analysis of the H-2K-gene product from the MHC mutant strain bml and from the C57BL/6 parent strain has been carried out in order to characterize the structural differences between parent and mutant K-gene products. Based on comparative tryptic peptide mapping of the cyanogen bromide fragments from these glycoproteins, two peptide differences were localized to the CN-Ia fragment. Partial amino-acid sequence analysis revealed two alterations in the primary structure of Kbml involving substitutions of tyrosine for arginine at position 155, and tyrosine for leucine at position 156. Both of these amino-acid replacements require a minimum of two nucleotide base changes at the nucleic acid level. These changes were the only alterations noted differentiating the Kbml and Kb glycoproteins. However, because our techniques allow us to analyze only 75 to 80 percent of the extra cellular portion of H-2Kb, it is possible there are other undetected changes. Nonetheless, the biochemical data are consistent with the hypothesis that the structural alterations noted in the Kbml mutant glycoprotein are directly related to the observed immunological specificity relative to the parent Kb molecule. Peptide comparisons of the Kb molecules of two C57BL/6 sublines and of the H-2b lymphoblastoid cell line, EL-4, disclosed no difference.
为了表征亲本和突变体K基因产物之间的结构差异,已对MHC突变株bml和C57BL/6亲本株的H-2K基因产物进行了生化分析。基于对这些糖蛋白溴化氰片段的胰蛋白酶肽图谱比较,发现两个肽差异定位于CN-Ia片段。部分氨基酸序列分析揭示了Kbml一级结构中的两个改变,即155位的精氨酸被酪氨酸取代,156位的亮氨酸被酪氨酸取代。这两个氨基酸替换在核酸水平上至少需要两个核苷酸碱基变化。这些变化是区分Kbml和Kb糖蛋白的唯一改变。然而,由于我们的技术仅能分析H-2Kb细胞外部分的75%至80%,所以可能存在其他未检测到的变化。尽管如此,生化数据与以下假设一致,即Kbml突变体糖蛋白中 noted 的结构改变与相对于亲本Kb分子观察到的免疫特异性直接相关。对两个C57BL/6亚系的Kb分子以及H-2b淋巴母细胞系EL-4的肽比较未发现差异。